The H4 minor histocompatibility antigen (HA) of mice includes a single immunogenic peptide presented by H-2K b molecules that stimulates skin allograft rejection and is immunodominant in the stimulation of cytolytic T lymphocytes (CTL) specific for multiple minor HA. We have identified H4 mimotopes that are recognized by the H4-specific M9 CTL clone through the use of a random peptide library comprised of bacterial clones expressing an inducible fusion protein tailed with the octamer sequence SXIXFXXL. Eight discrete mimotopes were identified that sensitized RMA-S cells for lysis by M9 CTL down to concentrations of 10 -11 M. Comparable reactivity was observed with a short-term, H4-specific CTL line indicating that the mimotopes were not solely specific for the selecting M9 clone. All mimotopes included Gly at p2 and either Val or Ile at p4, suggesting a requirement for a hydrophobic residue with specific conformation. All mimotopes included either Arg or His at p7, implicating a requirement for a specific positively charged amino acid at that position. The sixth position was more variable with four of eight mimotopes having a Val residue with single mimotopes including alternative amino acids, the majority of which were hydrophobic. Analysis of mimotopes for hydrophobicity and charge by reverse-phase HPLC and capillary electrophoresis respectively indicated that (i) mimotopes with Val at both p4 and p6 were hydrophobically similar (but not identical) to the natural H4 peptide, and (ii) a S → E substitution at p1 resulted in a peptide (EGIVFVRL) with charge characteristics equivalent to those of the natural H4 peptide.
Introduction
Minor histocompatibility antigens (HA) in mice and humans stimulate the rejection of allografts that are matched with recipients at the MHC. Depending upon the tissue/organ, multiple minor HA provide a formidable barrier to allograft survival. Skin allografts exchanged between mice of different inbred strains that are H2 compatible are rejected with speeds comparable to those observed for H2-mismatched grafts (1, 2) . The basis for antigenicity of minor HA lies in their inclusion of immunogenic peptides that are presented by class I and class II molecules; minor HA peptides presented by class I molecules are derived from endogenous proteins, and processed and transported to the endoplasmic reticulum as are other endogenous peptides. The selective presentation of individual minor HA by specific class I molecules is presumably based on the inclusion of anchor residues in motifs that promote binding to specific class I molecules (3, 4) . Received 19 November 1997, accepted 18 December 1997 The understanding of the molecular basis for recognition of minor HA peptides has been hampered by the limited information on peptide sequences, and the differences between donor and recipient peptides. In recent years, a number of these peptides have been identified and sequenced. Early work by Rammensee and co-workers demonstrated that arrays of endogenous peptides could be separated by reverse-phase HPLC for the identification of fractions containing minor HA peptides by sensitization of targets for lysis by cytolytic T lymphocytes (CTL) (5, 6) . This work has been extended by coupling HPLC separations to mass spectrometry for the identification and sequencing of two human minor HA peptides recognized by CTL from patients suffering chronic graft versus host disease (7, 8) . Alternatively, methods in molecular biology have been utilized to identify and sequence (i) the MTF peptide encoded by the mitochondrial ND1 gene by mtDNA sequencing (9) , and (ii) two male-specific (HY) peptides encoded by Y-linked genes mapped by deletion mapping and subtractive hybridization (10, 11) .
The family of minor HA peptides is generally viewed as representative of endogenous peptides in general. However, there is no experimental basis on which to preclude the possibility that these peptides have distinguishing characteristics that set them apart from other endogenous peptides and facilitate their recognition by TCR. In this regard, experiments in our laboratory indicate that CDR3β in TCR expressed by in vitro-selected CTL specific for two dominant minor HA peptides, H4 and CTT-1, are characterized by net negative charges (12, 13) . Similar results were obtained through spectratype analysis of CDR3β expressed by skin allograftinfiltrating CTL specific for the H4 antigen (14) . These results raise the distinct possibility that these charges are involved in TCR binding to these two minor HA peptides through direct bonding to opposing charges in the C-terminal ends of these peptides. The positioning of CDR3β over class I-peptide complexes revealed by crystallography supports this hypothesis (15, 16) . Accordingly, it would be of considerable interest to investigate the potential roles of opposing charges in facilitating and stabilizing TCR recognition of complexes of class I molecules and minor HA peptides as a group.
Although sequencing of natural, minor HA peptides is an important contribution, such sequencing is labor and resource intensive, and may preclude analysis of multiple peptides. An alternative involves the selection of mimotopes that exhibit characteristics of natural peptides that are essential for class I binding and TCR recognition. This has been a successful approach for a D b -binding HY peptide (17) ; mimotopes selected from a random peptide library led to a consensus amino acid sequence that included negatively and positively charged residues in the same positions as the subsequently identified natural peptide (11) .
In this communication, we describe the selection of a panel of mimotopes from a random peptide library that are recognized by CTL clones and lines specific for the H4 peptide. These H4 mimotopes all include a positively charged residue, Arg or His, at the same position in the C-terminal end, thereby fulfilling the prediction based on net negative charges in the CDR3β of H4-specific TCR.
Methods

Mice
C57BL/6ByJ (B6), BALB/cByJ and C.B10-H2 b (BALB.B) mice were purchased from The Jackson Laboratory (Bar Harbor, ME), and housed in a barrier facility in the Mayo Clinic Division of Animal Medicine.
Mixed lymphocyte culture (MLC) and cell-mediated lympholysis assays B6 mice were primed with 2ϫ10 7 spleen cells from BALB.B donors. Primed responder spleen cells were harvested 14 days after priming and re-stimulated in MLC with irradiated stimulator spleen cells in Iscove's medium supplemented with 5ϫ10 -5 M 2-mercaptoethanol and 5% FCS as described (18) .
T cells expanded in MLC were harvested after 6 days, diluted to 0.5ϫ10 6 cells/ml, and re-stimulated with BALB.B stimulator cells (2.5ϫ10 6 /ml) and 5% rat concanavalin A (Con A) supernatant as a source of IL-2 (19) . Subsequent re-stimulations of CTL lines were performed at intervals determined by cell growth.
The cell-mediated lympholysis (CML) assay was performed after (i) 6 days of MLC or (ii) maximal expansion of CTL lines according to the described technique (18) . Target cells for testing the specificity of CTL for H4 were Con A-induced lymphoblasts labeled with 51 Cr. Five thousand Con A lymphoblast targets were mixed with CTL in microtiter wells to yield 5-20:1 effector:target (E:T) ratios and the plates were incubated for 4 h at 37°C. One hundred microliters of supernatant were harvested for counting in a γ-counter and the 51 Cr release from labeled targets was determined by the following equation: percent specific release ϭ (experimental releasespontaneous release)/(maximum release -spontaneous release)ϫ100. Maximum release and spontaneous release were the 51 Cr released during incubation with 2.5% Triton X-100 and medium alone respectively. Mean specific release (Ϯ SE) was determined for each E:T ratio. The CML assay was modified for peptide-sensitized RMA-S cells (20) with peptides. Titrated concentrations of synthetic peptides and aliquots of bacterial lysates were incubated with 1500 radiolabeled RMA-S cells in 100 µl Iscove's/10% FCS for 40 min at room temperature. CTL were added in 100 µl Iscove's/10% FCS to yield 40:1 E:T ratios and the remainder of the assay was performed as described above. Peptide sensitization assays included allogeneic and syngeneic Con A lymphoblast targets to confirm H4 specificity of tested CTL.
M9 CTL clone
The H4-specific M9 clone was derived from C57BL/10 mice primed in vivo with three weekly challenges of 1-2ϫ10 7 B10.129-H4 b spleen cells that had received 20 Gy irradiation; responder spleen cells were boosted in vitro with B10.129-H4 b stimulators. CTL were re-stimulated weekly with fresh stimulators and recombinant human IL-2. CTL clones were selected by conventional micromanipulation and continued, routine stimulation with B10.129-H4 b spleen cells in the presence of recombinant IL-2. Specificity of M9 cells for the H4 antigen was confirmed in CML assays with H4 congenic strain targets.
Screening of the random peptide library
The K b -restricted library was originally constructed by Gavin and co-workers (17) . The construction and the method of screening this library have been previously described (17) . As described, the MBP gene was tailed with oligonucleotides that included (i) flanking BamHI and PstI restriction sites, (ii) a sequence encoding the recognition sequence (IEGR) for the factor X a restriction endoproteinase, and (iii) 24 bp oligonucleotides that encoded SXIXFXXL octamers based on the sequence of the K b -binding ovalbumin peptide, SIINFEKL (21) . The placement of the factor X a recognition site and a termination codon immediately upstream and downstream respectively of the peptide-encoding sequence allowed the release of octamers from induced MBP-peptide fusion proteins. This library, with a total of~189,000 transformants, was distributed among seven 48-well microtiter plates at~563 transformants/well.
A preliminary screening of this library was performed. Thirtytwo six-well pools of bacteria from four plates were grown to mid-log phase in growth medium (LBG medium plus ampicillin), induced with IPTG, and lysed with lysozyme and three freeze-thaw cycles. MBP fusion proteins were purified on an amylose column (New England Biolabs) and peptides were released by digestion with factor X a (New England Biolabs) as described (17) . Peptides were isolated by ultrafiltration through Centriprep 10 filters (Amicon, Beverly, MA). Aliquots of peptide mixtures were added to radiolabeled RMA-S cells for mixture with CTL at 40:1 effector:target ratios to identify pools containing H4 mimotopes. The identification of H4 ϩ pools led to screening of the individual wells in these pools as well as the individual wells from the three untested 48-well plates. One milliliter cultures were grown to mid-log phase, induced, and lysed in 200 µl lysozyme buffer and three freeze-thaw cycles as described (17) . The lysates were digested with factor X a and 40 µl aliquots were mixed with radiolabeled RMA-S cells in a CML assay. Bacterial stocks from H4 ϩ wells were titrated to determine bacterial concentration. These stocks were diluted to 100 cells/ml and 100 µl was plated in flat-bottom 96-well plates for overnight growth. Aliquots of 60 µl were removed and brought to 100 µl with growth medium for induction. Bacteria were pelleted, resuspended in 200 µl PBS and lysed with four freeze-thaw cycles. After pelleting the debris, 40 µl of supernatant were mixed with RMA-S cells for a CML assay. Bacterial cultures expressing H4 mimotopes were streaked on agar plates and individual colonies were picked for 100 µl microcultures and final screening. Positive colonies were grown to saturation overnight and plasmids were extracted with a commercial plasmid miniprep kit (Qiagen, Santa Clarita, CA). Insert sequencing was performed by Dye Terminated PCR cycle sequencing (Applied Biosystems, Foster City, CA) using the M13-40 forward primer. Electrophoresis and detection of the products was performed on an ABI200 automated sequencer (Applied Biosystems) at the Mayo Clinic Molecular Biology Core Facility.
Peptide synthesis
Peptides were synthesized on a model 396 multiple peptide synthesizer (Advanced Chemtech, Louisville, KY) by Fmoc chemistry and purified by reverse-phase HPLC. The purity and identity of the synthetic peptides was confirmed by mass spectrometry.
K b stabilization assay
The specificity of synthetic peptide binding to K b molecules of RMA-S cells was quantitated by the previously described stabilization assay (22) . RMA-S cells were incubated overnight at 26°C, sensitized with peptides at a final concentration of 10 µM in the presence of Brefeldin A (BFA; 10 µg/ml) for 1 h at room temperature, washed to remove unbound peptide and incubated at 37°C for 4-6 h in the presence of BFA. Cells (3ϫ10 5 ) were washed and stained with the Y-3 mAb (in a pre-tested dilution of ascites) (23) . Antibody-labeled cells were incubated for 30 min with a FITC-conjugated anti-mouse antibody. All incubations were performed in 1% BSA in PBS at 4°C. The cells were washed and the analysis of 10 4 gated events per sample was performed on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA).
K b -bound peptide extraction
Peptides were extracted from K b molecules that had been immunoprecipitated from lysates of spleen cells harvested from BALB.B and (BALB.BϫBALB/c)F 1 mice that had been injected i.v. 9 days previously with Friend virus (generously provided by Dr K. Blank, Medical College of Pennsylvania and Hannemann University, Philadelphia, PA). Friend virustransformed spleen cells were washed in PBS and resuspended at 10 8 cells/ml in lysis buffer containing CHAPS detergent and a cocktail of protease inhibitors (24) . Cell lysates were passed over a Protein A-Sepharose column containing bound and cross-linked Y-3 mAb. Bound immune complexes were washed and eluted with 0.2 N acetic acid. Low M r peptide fractions were collected at this point by centrifugation through Centricon 3 filters (Amicon, Danvers, MD) as described (24) . High M r fractions were further denatured by incubation for 30 min at 37°C in 10% acetic acid; low M r peptide fractions were collected by ultrafiltration. The two peptide samples were lyophilized and pooled by redissolving in 200 µl of 0.1% TFA.
HPLC
Peptides were separated by reverse-phase HPLC on a mini reverse-phase column (Vydac 218TP52; 250ϫ2.1 mm; 10 µm) using an ABI 130A HPLC (Applied Biosystems) controlled by System Gold software (Beckman Instruments, Fullerton, CA). The gradient (5-100% buffer B) was generated over 13-80 min. Buffer A (0.1% TFA/5% acetonitrile/95% H 2 O) and buffer B (0.1% TFA/40% acetonitrile/60% H 2 O). Absorbance was monitored at a wavelength of 214 nm. The flow rate was 0.20 ml/min and 30 s fractions were collected in microtiter plates for lyophilization and storage at -70°C. Peptide fractions were redissolved in 25% methanol in water immediately prior to assay.
Capillary electrophoresis (CE) and solid-phase extraction capillary electrophoresis (SPE-CE)
Both modes of electrophoresis, CE and SPE-CE, were performed on a Beckman P/ACE 5510 instrument (Beckman Instruments, Foster City, CA) equipped with a monochromatic UV detector capable of monitoring A 200 nm and controlled by System Gold software which also provided for data analysis. The capillaries were bare fused silica with internal diameter of 75 µmϫ37 cm (CE) or 100 µmϫ57 cm (SPE-CE). Standard free zone electrophoresis was carried in a separation buffer consisting of 25 mM sodium phosphate (pH 7.0) with a separation voltage of 20 kV. SPE-CE was carried out as described (25) with a small packed bed of reversed-phase sorbant, C18 (JT Baker, Phillipsburg, NJ), fitted to the inlet section of the capillary (25) . This allows hydrophobic analytes in a large volume (up to 1.0 ml, Ͼ100 times the total capacity of the capillary) to be concentrated and released from the SPE inlet section in a controlled manner [by injection of a small volume of an organic eluant (90% ACN/1% HCl)] for electrophoretic separation. The large sample volume capacities allow for micropreparative recovery of the sample (26) .
Results
Mimotope selection
The SXIXFXXL peptide library consists of~1.9ϫ10 5 individual clones distributed among wells in seven 48-well plates to yield~563 clones/well (17) . Since four of the eight amino acid positions were fixed, it was uncertain that H4 mimotopes would be included in the library. A preliminary experiment was performed to test the feasibility of cloning H4 mimotopes. Bacteria in six-well pools from four plates were grown to midlog phase and induced with IPTG. Over-expressed MBP fusion proteins were purified from bacterial lysates by binding to and elution from an amylose column; purified MBP fusion proteins were cleaved with factor X a , and octapeptides were separated and collected by ultra-filtration. Aliquots of these peptide pools containing~3380 peptides were used to sensitize radiolabeled RMA-S cells for lysis with the M9 anti-H4 CTL clone. Four pools were identified that sensitized RMA-S cells for lysis indicating that these pools contained H4 mimotopes (data not shown).
Bacteria from the individual wells of the H4-positive pools and the remaining three 48-well plates were grown to midlog, induced with IPTG, and lysed with lysozyme and multiple freeze-thaw cycles. MBP fusion proteins were cleaved with factor X a , and aliquots of these digested lysates were used to sensitize RMA-S cells for lysis by M9 cells. Positive wells were limiting diluted to 10 cells/well in single 96-well plates for MBP over-expression and factor X a cleavage. H4-positive wells were identified by sensitization of RMA-S cells for lysis by M9 cells and bacteria from positive wells were streaked on LB agar/ampicillin plates for selection of individual clones for peptide extraction. H4-positive clones were identified from 12 original wells; the percentage 51 Cr release from RMA-S cells sensitized with lysates at all three stages of limiting dilution cloning from three representative, original wells are presented in Fig. 1 . Significant lysis was observed with these lysates at all three stages resulting in unambiguous identification of H4-positive wells. The oligonucleotides encoding the octapeptides from 12 mimotope-expressing clones were sequenced. The amino acid sequences of these octapeptides are presented in Table 1 . The SGIVFVHL peptide was expressed by two independent clones with identical nucleotide sequences and the SGIIFVRL peptide was expressed by two clones with different nucleotide sequences. Preliminary titrations of synthesized peptides revealed that the SSILFIAL and SVIGFFGL peptides sensitized RMA-S cells for lysis at concentrations equivalent to that of a control K b -binding peptide (VVYDFLKC) (27) derived from SV40 T antigen (data not shown). This low activity and the difficulty in obtaining single-copy sequences from these clones suggested that the bacterial clones may have carried two plasmids, and we excluded these peptides from further analysis.
The remaining eight H4 mimotopes share three characteristics. First, all peptides include a Gly amino acid at p2. Second, all mimotopes carry either a positively charged amino acid, Arg or His, at p7. The inclusion of one positively charged residue was predicted by our previous experiments separating peptides included in H4-positive HPLC fractions by SPE-CE under conditions of complete protonation (26) . The natural H4 peptide migrated as a doubly charged peptide indicative of inclusion of a positively charged amino acid. Further, the position of the Arg/His residues in the C-terminal end of H4 was predicted by the net negative charges that characterize CDR3β of H4-specific TCR (12) 
Recognition of H4 mimotopes by CTL clones and lines
These eight mimotopes were synthesized and titrated from 10 -6 to 10 -13 M for sensitization of RMA-S cells and mixture with M9 CTL in a standard CML assay ( Fig. 2A and B) . The majority of mimotopes sensitized RMA-S cells for 50% maximal lysis when present at~10 -11 M; this concentration is consistent with other sequenced minor HA peptides (7,11). These six mimotopes included Ile/Val at p4 and Ile, Val or Leu at p6, and there appeared to be no significant differences between these titration curves. Accordingly, there were no differences between mimotopes carrying Arg and His at p7. However, substitution of either Tyr or Arg at p6 resulted in a significant reduction in activity (Fig. 2B) . These results pointed to a requirement for specific hydrophobic residues at both p4 and p6 with more latitude for substitutions at p6.
Since these H4 mimotopes had been identified through the use of a single CTL clone, it was possible that they were specific for that single clone and its TCR. Such was the case for the originally described HY mimotopes where considerable differences in mimotope recognition were observed for different HY-specific clones and lines (17) . Therefore, we tested the H4 mimotopes with a short-term CTL line specific for the CTT-2 peptide expressed by BALB.B cells (24) . We have previously shown that the H4 and CTT-2 peptides are both encoded by genes in the same segment of chromosome 7 and they exhibit identical migrations in both reverse-phase HPLC and SPE-CE supporting their identity (26) . It was felt that the use of CTT-2-specific CTL after a limited number of rounds of stimulation in vitro would provide a stringent test of the characteristics of the H4 mimotopes. B6 mice were primed with BALB.B spleen cells and boosted in culture with BALB.B stimulators for two rounds of stimulation in the presence of IL-2. These CTL were tested with RMA-S cells sensitized with titrated concentrations of the H4 mimotopes ( Fig. 3A and B) . As observed with the M9 CTL, all mimotopes sensitized RMA-S cells for lysis and the highest levels of lysis were observed with mimotopes including Ile, Val or Leu at p6. Unlike M9 CTL, these CTT-2-specific CTL Fig. 1 . H4-specific cytolysis of RMA-S targets sensitized with factor X a -digested bacterial lysates from different stages of mimotope cloning. Lysates from IPTG-induced bacterial cultures were digested with factor X a and aliquots were used to sensitize RMA-S cells for lysis by H4-specific M9 CTL. The cultures contained 563 (first screen), 10 (second screen) and one colony/culture (third screen). 
recognized the mimotope with Arg at p6 with reactivity comparable to that of the other mimotopes with the exception of the mimotope expressing Tyr that exhibited the lowest activity. Therefore, there appeared to be limited differences between the recognition of the H4 mimotopes by the M9 CTL clone and a short-term CTT-2-specific CTL line.
Stabilization of K b expression by H4 mimotopes
The facts that RMA-S cells can be sensitized for lysis by these mimotopes and H4 is presented by K b molecules indicate that the H4 mimotopes bind to K b molecules. However, we wanted to determine the relationship between activity and binding as well as the relationship between H4 mimotope binding and that of other K b -binding, immunogenic peptides. The binding of the H4 mimotopes was compared to that of a K b -binding SV40 T antigen peptide (VVYDFLKC) and the VP2 121-130 immunogenic peptide (FHAGSLLVFM) that binds to D b molecules and is encoded by the VP2 gene of Theiler's virus (28) . RMA-S cells were treated with 10 µM concentrations of peptides at 26°C in the presence of BFA to reduce the transport of newly synthesized K b molecules. Peptide-labeled RMA-S cells were incubated at 37°C for 4-6 h after which they were labeled with the K b -specific Y-3 antibody and FITClabeled goat anti-mouse Ig. The H4 mimotopes uniformly stabilized cell surface expression of K b molecules over this range of incubation time (Fig. 4) . The level of stabilization was comparable to that obtained with the VVYDFLKC peptide and significantly higher than the marginal stabilization observed with the D b -binding VP2 121-130 peptide. The uniform binding of all of the H4 mimotopes suggested that the decreased sensitization activity observed with the mimotopes including Tyr and Arg at p6 was not due to decreased binding but was most likely due to an effect on TCR recognition.
H4 mimotope separation by HPLC
The natural H4 peptide elutes as a single peak in reversephase HPLC whether derived from B10.129-H4 b or BALB.B cells (18, 24) . We subjected the H4 mimotopes to reversephase HPLC analysis to identify the mimotope(s) that exhibited an elution time most closely related to that of the natural H4 peptide. The panel of mimotopes was separated by reverse-phase HPLC in pair-wise combinations with two marker peptides, M1 (HIYEFPQL) and M2 (VP2 121-130 ) (Fig. 5) . The M1 peptide was included since it had been originally collected in H4-positive HPLC fractions and was separated by SPE-CE for sequencing (data not shown). Although the M1 peptide co-elutes with the natural Fig. 2 . Sensitization of RMA-S cells with titrated mimotopes for lysis by M9 CTL. RMA-S cells were sensitized with titrated concentrations (1 µM to 100 fM) of eight H4 mimotopes; dilutions were made with pipette tips changed between each dilution to eliminate carry-over. M9 cells were added at an E:T ratio of 30:1.
H4 peptide in reverse-phase HPLC separations, it exhibits no H4 activity. With the exception of the SGIIFRRL mimotope, all mimotopes eluted after the M1 peptide. Of the eight active mimotopes, the two mimotopes that included Val at both positions 4 and 6 were the closest to eluting at the time of the M1 marker. The SGIVFVRL and SGIVFVHL peptides eluted in one peak (Fig. 5A) suggesting that Arg and His had equal effects on elution times under these conditions of low pH. Therefore, it appeared that the SGIVFVRL and SGIVFVHL were most closely related to the natural H4 peptide in terms of hydrophobicity.
H4 mimotope separation by SPE-CE
The identical elution times of the SGIVFVRL and SGIVFVHL mimotopes show that the difference in charge characteristics of these two amino acids in these mimotopes is undetectable under these reverse-phase HPLC conditions. However, both negatively and positively charged amino acids have a profound effect on migration in CE when a buffer pH is used that differentially affects positively and negatively charged amino acid residues. We have separated peptides in H4-positive HPLC fractions by SPE-CE; this technique enables us to extract peptides from the relatively large volumes of HPLC fractions and subsequently separate them by CE (25) . This method involves the placement of C8 reverse-phase packing upstream of the capillary such that introduced peptides are bound to the matrix, eluted by organic solvent (90% ACN/1% concentrated HCl in water) and subsequently separated by CE (25) . In order to obtain samples containing the natural H4 peptide for separation by SPE-CE, K b molecules were immunoprecipitated from Friend virus-transformed BALB.B spleen cells, and peptides were extracted by acid hydrolysis and separated by reverse-phase HPLC. Fractions were tested for H4 peptide activity by sensitizing RMA-S cells that were mixed with M9 CTL. We separated peptides from these natural H4-positive HPLC fractions by SPE-CE with an electrophoresis buffer of pH 7, and compared their migration relative to known peptide markers and the point [(electroosmotic flow (EOF)] where electrical current is altered by the change in buffer associated with exit of the elution buffer from the outlet end of the capillary (25) . Fractions were collected at timed intervals and tested for H4 activity by sensitization of RMA-S cells that were mixed with M9 CTL. Since the UV detector in a capillary is located 7 cM from the outlet, an adjustment, based on the length of the run, was made for time of migration over that distance to correlate activity in collected fractions with absorbance measured by the detector. As can be seen in Fig. 6(A and B) , H4 activity correlated with migration of the M2 marker peptide (ESIAFLSRL) that migrated just after the EOF in a separate run under identical conditions.
The strong dependence of migration in CE at pH 7 on specific negatively and positively charged amino acids, and the migration of the natural H4 peptide with the M2 marker suggested that the natural H4 peptide contained both Arg and a negatively charged amino acid. Based on the apparent requirement for specific hydrophobic residues at p4 and p6, and the fact that the peptide library included fixed residues at p1 and p3, we synthesized two additional peptides with Glu at p1: EGIVFVRL and EGIVFVHL. These variants and their two respective mimotope counterparts were separated by analytical CE at pH 7 in the presence of three marker peptides (Fig. 6C) . The SGIVFVRL mimotope migrated at the front of the EOF, and the EGIVFVHL peptide migrated after the M2 peptide and close to the M1 peptide (HIYEFPQL). The SGIVFVHL peptide migrated between the M2 (ESIAFLSRL) and M3 (ASTYKFFEV) peptides, and the EGIVFVRL peptide migrated at the same time as the M2 peptide. In terms of charge characteristics, it appears that the EGIVFVRL peptide is most closely related to the natural H4 peptide.
The EGIVFVRL and EGIVFVHL variants were tested for their ability to sensitize RMA-S targets for lysis by M9 and B6 anti-BALB.B CTL (Fig. 7) . Both peptides sensitized these targets for lysis by M9 cells with activity commensurate with the SGIVFVRL and SGIVFVHL peptides (Fig. 7A) , but the EGIVFVRL peptide appeared to have lower activity when tested with B6 anti-BALB.B CTL (Fig. 7B) . Both of these variants stabilized K b molecules at levels comparable to their 'wild-type' counterparts (Fig. 4) and eluted in reversephase HPLC with times comparable to their wild-type peptides (Fig. 5) . The elution of the EGIVFVRL mimotope in reversephase HPLC relative to that of the natural H4 peptide was confirmed by performing a separation of EGIVFVRL combined with peptides extracted from K b molecules of H4 ϩ (BALB.BϫBALB/c)F 1 cells. Fractions were collected and used to sensitize RMA-S cells for lysis by M9 CTL (Fig. 8A) . Two peaks of activity were observed: the first at 49 min and the second at 51-52 min. Comparison of this activity with a replicate HPLC separation of the M1 marker and EGIVFVRL (Fig. 8B) indicated that the activity at 51-52 min was due to the EGIVFVRL peptide and the activity at 49 min was due to the natural H4 peptide co-eluting with the M1 marker. These results corroborated those described in Fig. 5 showing that the mimotopes carrying Val residues at p4 and p6 were the most closely related, but not identical, to the natural H4 peptide in terms of hydrophobicity.
Discussion
The strategy of mimotope selection has been successfully used to identify mimotopes for an HY peptide presented by D b molecules (17) ; the natural HY peptide was subsequently identified and corresponded closely to the consensus sequence predicted by the mimotopes (11) . This strategy is focused on identifying peptides that share amino acids with the natural, immunogenic peptide that have a significant impact on both class I binding and recognition by specific TCR; there is no presumption that any of the identified mimotopes will be identical to the natural peptide. We have used this approach to identify mimotopes of the H4 minor HA peptide. The recognition of these H4 mimotopes by the selecting CTL clone as well as a polyclonal CTL line indicates that these peptides are not simply specific for a single TCR but, rather, are recognized by a diverse set of H4-specific TCR strengthening the contention that they share characteristics essential for recognition of the natural H4 peptide. The TCR expressed in short-term CTL lines specific for the H4 peptide are oligoclonal in terms of V α and V β usage with no required usage of any single V α or V β gene (12, 13) .
The relationship between the amino acids at degenerate positions in the H4 mimotopes and binding to K b molecules and recognition by TCR is brought into focus by modeling the SGIVFVRL:K b complex relative to the published complex of K b and the VSV8 peptide (RGYVYQGL) (29, 30) . Energy minimization was carried out for the two structures in a completely solvated crystal lattice utilizing the crystallographic symmetry of the K b :VSV8 structure (31, 32) . Electrostatic surface potentials were calculated and molecular surfaces were rendered using the program GRASP (33) . The molecular surface of the SGIVFVRL:K b complex and the comparison of conformations of bound VSV8 and SGIVFVRL peptides are presented in Fig. 9 . The conformations of these two peptides are similar, with the Sp1, Vp4 and Rp7 amino acids of SGIVFVRL orienting out toward the TCR as predicted (29, 30) . The Gp2 amino acid fulfills requirements for a relatively small amino acid due to the relatively restricted size of pocket B in K b molecules (29) . The exclusive inclusion of this amino acid suggests a requirement for flexibility in the H4 mimotope backbone since K b molecules can accept Ile at p2 when Phe is present at p5 due to the smaller side chain of this amino acid relative to the alternative Tyr anchor (4, 34) . Further, mutation of Gp2 in VSV8 to Ala had a limited effect on recognition of VSV8 by only 2/12 CTL clones (35) .
According to the model in Fig. 9 , the neutral Val residue at p4 in SGIVFVRL orients toward the TCR. The apparent requirement for this relatively hydrophobic residue and the Ile alternative in the H4 mimotopes is similar to the requirement for Vp4 in VSV8 since an Ala substitution at that position virtually eliminated recognition by eight of 12 CTL clones (35) . The effect of this residue on TCR recognition may be similar to that of the Yp5 residue in the reported Tax:HLA-A2 structure, where it occupies the deep void formed by the boundaries of CDR3α and CDR3β of the TCR (36) . A similar pocket has been observed with the mouse 2C TCR (15) . The exclusion of Leu at this position in the H4 mimotopes suggests that the conformation of the side chain is important and the more linear side chain of Leu does not favor effective recognition by CTL. Despite the prominence of Val at p6, there appears to be more flexibility in alternative amino acids; the model in Fig. 9 predicts that this amino acid is buried in the K b cleft and will not affect recognition as long as it favors binding, hence the three alternative hydrophobic residues. All highly active mimotopes included an Arg or His residue at p7, suggesting the requirement for a specific positive charge at this position. Molecular modeling suggests that this amino acid prominently orients toward the TCR and makes a significant contribution to the net charge of the H4:K b surface contacted by the CDR3β (Fig. 9) . The inclusion of a positively charged residue in H4 was predicted by migration of the natural H4 peptide in SPE-CE, since it migrated as a doubly charged peptide under conditions of low pH and complete protonation (26) . Further, we reported that CDR3β of H4-specific CTL clones were characterized by net negative charges (12, 13) , prompting the speculation that the postulated positive charge was located in the C-terminal end of the peptide where it could interact with CDR3β through salt bridge formation. This hypothesis was based on the crystal structures of mouse and human TCR that demonstrated that CDR3β interacts with the C-terminal end of bound peptides as well as neighboring residues in the class I α helices (15, 36) .
The positive charge at p7 may also be involved directly in the binding of the H4 mimotopes to K b molecules. We showed in early studies that the K bm11 and K bm3 mutations resulted in reduction and elimination respectively of the amount of natural H4 peptide that could be extracted from immunoprecipitated K b molecules from H4 ϩ cells (18) . These mutants share an Asp→Ser substitution at position 77 on the α 1 helix as well as additional, single amino acid substitutions (37) . The Asp→Ser interchange may have disrupted a favorable interaction between position 77 and p7 resulting in reduced binding. The effect of the K bm11 mutation was also revealed in the distribution of negatively charged residues in H4-specific CDR3β that were restricted by K bm11 molecules. This substitution resulted in an increase in representation of negatively charged residues at the C-terminal ends of CDR3β (12) , suggesting that the loss of Asp at position 77 altered the orientation of Rp7 favoring salt bridge formation with CDR3β. Support for an interaction between Asp at position 77 and Rp7 comes from the comparison of SGIVFVRL:K b and VSV8:K b structures. Root-mean-square displacement calculations using the X-PLOR program (32) indicated significant backbone displacement of positions 76 and 77 in the Fractions were collected at 30 s intervals and used to sensitize RMA-S cells for lysis by M9 CTL. The percentages of lysis with individual fractions are denoted by the bars of lytic activity; the difference in time between the absorbance reading and the collection of the migrating fractions has been accounted for (7 cM from detector to outlet). The position of the EOF where the exiting of the elution buffer from the outlet of the capillary results in a change in electrical current is bracketed as a point of reference. (B) Two marker peptides were separated by SPE-CE under identical conditions; M1 is HIYEFPQL and M2 is ESIAFLSRL. The position of the EOF is bracketed. (C) The SGIVFVRL and SGIVFVHL mimotopes and their Sp1E variants were separated by analytical CE at pH 7. The M1, M2 and M3 markers were included in the separation, and the EOF is bracketed as a frame of reference. former structure, pointing toward an interaction with the SGIVFVRL peptide that did not occur with VSV8 (data not shown).
The co-migration in SPE-CE (pH 7) of the natural H4 peptide with a marker peptide that included Glu and Arg residues strongly suggested that the natural peptide included both of these residues. It appeared that p1 was the likely location of such a negatively charged residue since it was fixed as Ser in the degenerate peptide library and the other fixed positions occupied K b pockets. Although the EGIVFVRL peptide migrated similarly to the natural H4 peptide in SPE-CE, there was no apparent increase in activity associated with this interchange. Modeling of the EGIVFVRL:K b structure suggests a structure similar to that of SGIVFVRL:K b where the Ep1 residue orients toward the TCR (data not shown). The possibility also exists that Asp occupies p1 since SPE-CE (pH 7) will not distinguish between Glu and Asp. Experiments are in progress which involve screening a new peptide library with only the p5 and p8 positions fixed in order to determine the preferences, if any, of H4-specific TCR for residues at p1.
The selection of H4 mimotopes has enabled us to identify specific residues that enable K b -bound peptides to be recognized by H4-specific CTL. As shown by comparisons of the natural H4 peptide and the selected mimotopes in reversephase HPLC, we have not identified the true natural peptide. However, we have identified peptides that carry the characteristics of this peptide that are required for recognition by CTL. As such, the mimotopes should serve as useful surrog- ates for the analysis of the molecular basis for recognition of the H4 peptide. Similar roles could be filled by mimotopes of tumor-specific/associated peptides. Identification of these peptides has historically involved either cDNA/DNA cloning (38) or identification and sequencing by reverse-phase HPLC coupled to tandem mass spectrometry (39) . Both of these approaches have resulted in the identification of natural, immunogenic peptides. The latter approach is limited by the relatively large numbers of cells required for peptide analysis (39) , thereby placing many tumors out of reach because such numbers simply cannot be grown in vitro. More importantly, the exact sequence of the natural peptide is not required for an effective immunogen as exemplified by the ability of HY mimotopes to prime CTL responses to the natural HY peptide (17) . Knowledge of the amino acid sequence that confers immunogenicity and cross-reactivity with the natural, immunogenic peptide is all that is required, and mimotopes can clearly provide such information. Fig. 9 . Molecular modeling of the SGIVFVRL:K b structure based on the VSV8:K b structure. Mutation of the peptide in the VSV8:K b crystal structure (PDB code 1VAA) to generate the SGIVFVRL:K b structure was done using the program O (31). Energy minimization was carried out for the two structures in a completely solvated crystal lattice utilizing the crystallographic symmetry of the K b :VSV8 structure. Solvation, energy minimization and root-mean-square displacement calculations were carried out using the program X-PLOR (32) . (A) Electrostatic surface potentials were calculated and molecular surfaces were rendered using the program GRASP (33) . Colors from red (-10 kT) to white (0.0 kT) to blue (ϩ10 kT) represent electrostatic potential at the molecular surface. (B) Side views of the conformations of bound SGIVFVRL (red) and VSV8 peptides (blue).
